Page last updated: 2024-11-12
hamigeran b
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
hamigeran B: has antiviral activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 9976066 |
CHEMBL ID | 380587 |
MeSH ID | M0464667 |
Synonyms (3)
Synonym |
---|
hamigeran b |
CHEMBL380587 |
(1r,3ar,9br)-7-bromo-6-hydroxy-3a,8-dimethyl-1-propan-2-yl-1,2,3,9b-tetrahydrocyclopenta[a]naphthalene-4,5-dione |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (6)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID255785 | In vitro cytotoxicity against leukemia P-388 tumor cells | 2005 | Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18 | Joys of molecules. 2. Endeavors in chemical biology and medicinal chemistry. |
AID378904 | Cytotoxicity against mouse P388 cells | 2000 | Journal of natural products, Jan, Volume: 63, Issue:1 | Chemistry of sponges. 19. Novel bioactive metabolites from Hamigera tarangaensis. |
AID378913 | Antiviral activity against Poliovirus | 2000 | Journal of natural products, Jan, Volume: 63, Issue:1 | Chemistry of sponges. 19. Novel bioactive metabolites from Hamigera tarangaensis. |
AID378905 | Antibacterial activity against Escherichia coli | 2000 | Journal of natural products, Jan, Volume: 63, Issue:1 | Chemistry of sponges. 19. Novel bioactive metabolites from Hamigera tarangaensis. |
AID378906 | Antifungal activity against Candida albicans | 2000 | Journal of natural products, Jan, Volume: 63, Issue:1 | Chemistry of sponges. 19. Novel bioactive metabolites from Hamigera tarangaensis. |
AID378912 | Antiviral activity against Herpesvirus | 2000 | Journal of natural products, Jan, Volume: 63, Issue:1 | Chemistry of sponges. 19. Novel bioactive metabolites from Hamigera tarangaensis. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (60.00) | 29.6817 |
2010's | 5 (33.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.17
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.17) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |